Carisoprodol
- Product NDC
- 58657-645
- 11-digit product format
- 586570645
- Labeler code
- 58657
- Product ID
- 58657-645_eda05c23-89fc-0c96-e053-2a95a90a5ceb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Carisoprodol
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Method Pharmaceuticals, LLC
- Application
- ANDA040245
- Marketing category
- ANDA
- Marketing start
- 2019-08-08
- Marketing end
- 0000-00-00
- Substance
- CARISOPRODOL
- Active strength
- 350 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 58657-645-01 | 58657064501 | 100 TABLET in 1 BOTTLE (58657-645-01) | 100 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |
| 58657-645-10 | 58657064510 | 1000 TABLET in 1 BOTTLE (58657-645-10) | 1000 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |
| 58657-645-50 | 58657064550 | 500 TABLET in 1 BOTTLE (58657-645-50) | 500 tablet | 2019-08-08 | 0000-00-00 | No | No | Current |